The Role of Cytogenetic Risk Stratification in FLT3 Mutated NPM1 Negative AML Patients Undergoing Allogeneic Stem Cell Transplantation (alloSCT) in Remission: A Study on Behalf of the ALWP of the EBMT

Authors :: I. Yakoub-Agha
J Byrne
Hélène Labussière-Wallet
William Arcese
Tobias Gedde-Dahl
Jan J. Cornelissen
Riitta Niittyvuopio
Charles Craddock
Mohamad Mohty
Jordi Esteve
M. Labopin
Arnon Nagler
Jonathan Canaani
Gérard Socié
Noel Milpied
Source :: Transplantation and Cellular Therapy. 27:S55-S56
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
Transplantation
medicine.medical_specialty
NPM1
business.industry
Cell Biology
Hematology
Internal medicine
Risk stratification
medicine
Molecular Medicine
Immunology and Allergy
Stem cell
business

Tools